StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn cash

Cash and short-term investments held at the end of each period.

CytoDyn's cash was $16.36M at Aug 31, 2026. For fiscal 2026 it was $11.85M, down 0.4% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $33.94M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2026May 31, 2026$11.85M-0.4%
FY2025May 31, 2025$11.90M+21.3%
FY2024May 31, 2024$9.81M+8.5%
FY2023May 31, 2023$9.05M+113.9%
FY2022May 31, 2022$4.23M-87.5%
FY2021May 31, 2021$33.94M+137.7%
FY2020May 31, 2020$14.28M+311.9%
FY2019May 31, 2019$3.47M+181.6%
FY2018May 31, 2018$1.23M-30.7%
FY2017May 31, 2017$1.78M-81.6%
FY2016May 31, 2016$9.64M+818.2%
FY2015May 31, 2015$1.05M-78.5%
FY2014May 31, 2014$4.89M+709.4%
FY2013May 31, 2013$603.68K+111.8%
FY2012May 31, 2012$284.99K-72.5%
FY2011May 31, 2011$1.04M+48.2%
FY2010May 31, 2010$700.50K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$16.36M+75.3%
Q4 FY2026CQ2 2026May 31, 2026$11.85M-0.4%
Q3 FY2026CQ1 2026Feb 28, 2026$15.66M-4.5%
Q2 FY2026CQ4 2025Nov 30, 2025$4.98M-76.6%
Q1 FY2026CQ3 2025Aug 31, 2025$9.33M-62.6%
Q4 FY2025CQ2 2025May 31, 2025$11.90M+21.3%
Q3 FY2025CQ1 2025Feb 28, 2025$16.40M+1068.1%
Q2 FY2025CQ4 2024Nov 30, 2024$21.34M+14413.6%
Q1 FY2025CQ3 2024Aug 31, 2024$24.92M+1125.2%
Q4 FY2024CQ2 2024May 31, 2024$9.81M+8.5%
Q3 FY2024CQ1 2024Feb 29, 2024$1.40M-41.6%
Q2 FY2024CQ4 2023Nov 30, 2023$147.00K-96.9%
Q1 FY2024CQ3 2023Aug 31, 2023$2.03M-51.9%
Q4 FY2023CQ2 2023May 31, 2023$9.05M+563.8%
Q2 FY2023CQ4 2022Nov 30, 2022$2.40M-72.9%
Q1 FY2023CQ3 2022Aug 31, 2022$4.68M-28.4%
Q4 FY2022CQ2 2022May 31, 2022$4.23M-87.5%
Q3 FY2022CQ1 2022Feb 28, 2022$1.36M-90.5%
Q2 FY2022CQ4 2021Nov 30, 2021$8.88M-69.8%
Q1 FY2022CQ3 2021Aug 31, 2021$6.53M-64.1%
Q4 FY2021CQ2 2021May 31, 2021$33.94M+137.7%
Q3 FY2021CQ1 2021Feb 28, 2021$14.29M+102.5%
Q2 FY2021CQ4 2020Nov 30, 2020$29.41M+2350.6%
Q1 FY2021CQ3 2020Aug 31, 2020$18.20M+913.4%
Q4 FY2020CQ2 2020May 31, 2020$14.28M+311.9%
Q3 FY2020CQ1 2020Feb 29, 2020$7.06M+342.8%
Q2 FY2020CQ4 2019Nov 30, 2019$1.20M+55.4%
Q1 FY2020CQ3 2019Aug 31, 2019$1.80M-62.2%
Q4 FY2019CQ2 2019May 31, 2019$3.47M+181.6%
Q3 FY2019CQ1 2019Feb 28, 2019$1.59M-67.8%
Q2 FY2019CQ4 2018Nov 30, 2018$772.36K-40.4%
Q1 FY2019CQ3 2018Aug 31, 2018$4.75M+401.9%
Q4 FY2018CQ2 2018May 31, 2018$1.23M-30.7%
Q3 FY2018CQ1 2018Feb 28, 2018$4.95M-36.5%
Q2 FY2018CQ4 2017Nov 30, 2017$1.30M-85.3%
Q1 FY2018CQ3 2017Aug 31, 2017$946.25K-78.7%
Q4 FY2017CQ2 2017May 31, 2017$1.78M–
Q3 FY2017CQ1 2017Feb 28, 2017$7.80M–
Q2 FY2017CQ4 2016Nov 30, 2016$8.81M–
Q1 FY2017CQ3 2016Aug 31, 2016$4.44M–

More CytoDyn figures

See a number that looks wrong?